Dynamk Capital
Overview
Venture and growth equity fund focused entirely on Life Sciences Industrials - tools, technologies and services fundamental to biopharma. We provide the fuel, resources and capital life science entrepreneurs need
Investment Focus
- Innovative life science technologies
- Early-stage companies
- Disruptive tools and services for biopharmaceutical industry
Portfolio Companies
Get the full list of 54,000+ investors
Dynamk Capital and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Dynamk Capital
What sectors does Dynamk Capital invest in?
Dynamk Capital invests in Artificial Intelligence, Life Sciences, Pharmaceuticals, Medical Devices, Bioinformatics and Machine Learning, and is based in New York, United States. Dynamk Capital is listed as a vc in the ConnectSafely investor database.
What stage does Dynamk Capital invest at?
Dynamk Capital backs companies at Seed, Early Stage, Series A, Series B and Growth, writing cheques of 500K - 700K.
Which regions does Dynamk Capital invest in?
Dynamk Capital invests across United States.
What companies has Dynamk Capital invested in?
Dynamk Capital's portfolio includes Envisagenics, RoosterBio, Alpenglow Biosciences, Virica Biotech, Vectron Biosolutions, Curibio, Lucid Scientific and CellFE Biotech.
How do I contact Dynamk Capital?
Dynamk Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
